Related references
Note: Only part of the references are listed.siRNA therapeutics: a clinical reality
Phei Er Saw et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment
Hui Xing et al.
ACTA PHARMACOLOGICA SINICA (2020)
Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses
Tuan M. Nguyen et al.
CELL RESEARCH (2020)
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott et al.
CELL (2020)
Host-Directed Antiviral Therapy
Naveen Kumar et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
The emerging role of RNA modifications in the regulation of mRNA stability
Sung Ho Boo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology
Yuhua Weng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn et al.
MOLECULAR THERAPY (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan et al.
ACS NANO (2020)
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Yuhao Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
Changhua Yi et al.
VIROLOGICA SINICA (2020)
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
Fran Robson et al.
MOLECULAR CELL (2020)
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
Jing Lu et al.
CELL RESEARCH (2020)
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Laura Riva et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
Jesse H. Erasmus et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Evolution of the COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Paving the Road for RNA Therapeutics
Niels Dammes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Vaccines against COVID-19
Camille Locht
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2020)
The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
Craig Steven McLachlan
CLINICAL HYPERTENSION (2020)
Targeting RNA: A Transformative Therapeutic Strategy
Wei Yin et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Identification of preexisting adaptive immunity to Cas9 proteins in humans
Carsten T. Charlesworth et al.
NATURE MEDICINE (2019)
Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
Danny Wilbie et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
CRISPR-Cas based targeting of host and viral genes as an antiviral strategy
Lulia Koujah et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Significant inhibition of re-emerged and emerging swine enteric coronavirus in vitro using the multiple shRNA expression vector
Kai Li et al.
ANTIVIRAL RESEARCH (2019)
Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p. Phe508del cystic fibrosis
Wouter Beumer et al.
PLOS ONE (2019)
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Immunogenicity for antisense oligonucleotides: a risk-based assessment
Christopher C. Stebbins et al.
BIOANALYSIS (2019)
ICTV Virus Taxonomy Profile: Nodaviridae
A. S. Sahul Hameed et al.
JOURNAL OF GENERAL VIROLOGY (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Antisense oligonucleotides
Daniel R. Scoles et al.
NEUROLOGY-GENETICS (2019)
Advances in mRNA Vaccines for Infectious Diseases
Cuiling Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Silvana Konermann et al.
CELL (2018)
Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein
Winston X. Yan et al.
MOLECULAR CELL (2018)
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
Annette B. Vogel et al.
MOLECULAR THERAPY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
A review on current status of antiviral siRNA
Abid Qureshi et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
Shuliang Chen et al.
VIRUSES-BASEL (2018)
Nusinersen for Spinal Muscular Atrophy Are We Paying Too Much for Too Little?
Vinay Prasad
JAMA PEDIATRICS (2018)
The Impact of CRISPR-Cas System on Antiviral Therapy
Hadi Bayat et al.
ADVANCED PHARMACEUTICAL BULLETIN (2018)
Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer
Sara Karaki et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice
Jeff R. Crosby et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans
Jasper Adriaan Soppe et al.
TRENDS IN MICROBIOLOGY (2017)
RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?
Zhongji Meng et al.
FRONTIERS IN IMMUNOLOGY (2017)
Minimal 2′-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity
Megan Basila et al.
PLOS ONE (2017)
ISS-N1 MAKES THE FIRST FDA-APPROVED DRUG FOR SPINAL MUSCULAR ATROPHY
Eric W. Ottesen
TRANSLATIONAL NEUROSCIENCE (2017)
Safety of antisense oligonucleotide and siRNA-based therapeutics
Xuan Chi et al.
DRUG DISCOVERY TODAY (2017)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
Jasper F. W. Chan et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
RNA-Based Vaccines in Cancer Immunotherapy
Megan A. McNamara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
Martin Sebastian et al.
BMC CANCER (2014)
Local and systemic tolerability of a 2′O-methoxyethyl antisense oligonucleotide targeting interleukin-4 receptor-α delivery by inhalation in mouse and monkey
Robert A. Fey et al.
INHALATION TOXICOLOGY (2014)
Programmable RNA recognition and cleavage by CRISPR/Cas9
Mitchell R. O'Connell et al.
NATURE (2014)
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
Steffen Rausch et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment
Jin Huk Choi et al.
BIODRUGS (2013)
Development and Preclinical Efficacy of Novel Transforming Growth Factor-β1 Short Interfering RNAs for Pulmonary Fibrosis
Corina N. D'Alessandro-Gabazza et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
RNA-guided genetic silencing systems in bacteria and archaea
Blake Wiedenheft et al.
NATURE (2012)
Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2
Eva Boettcher-Friebertshaeuser et al.
JOURNAL OF VIROLOGY (2011)
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Katalin Kariko et al.
NUCLEIC ACIDS RESEARCH (2011)
Recent Progress in Chemically Modified siRNAs
M. Gaglione et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Josiane E. Garneau et al.
NATURE (2010)
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
John DeVincenzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Effects of Aerosolized STAT1 Antisense Oligodeoxynucleotides on Rat Pulmonary Fibrosis
Wenjun Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis
Cheng-Xiong Xu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells
C. -Y. Lu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models
Renaud Burrer et al.
JOURNAL OF VIROLOGY (2007)
Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S
Sara Akerstrom et al.
ANTIVIRAL RESEARCH (2007)
Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus
Ming-Liang He et al.
FEBS LETTERS (2006)
Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers
BW Neuman et al.
JOURNAL OF VIROLOGY (2005)
Antisense morpholino-oligomers directed against the 5′ end of the genome inhibit coronavirus proliferation and growth
BW Neuman et al.
JOURNAL OF VIROLOGY (2004)
HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers
HM Moulton et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2003)
The promise of nucleic acid vaccines
NP Restifo et al.
GENE THERAPY (2000)
Share Paper
